HOME
Leading the way to a cure

SCIENTIFIC PUBLICATIONS BY ALR FUNDED RESEARCHERS

Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation - Franck J. Barrat Ph.D.

August 7, 2006

Human plasmacytoid DCs (PDCs) represent a central cell type of the immune system (1, 2) that can participate to two of its critical activities. First, they can produce substantial amounts of type I IFN in response to a variety of pathogens, including viruses or parasites (3–6). PDC recognition of viruses is mediated primarily by recognition of the RNA or DNA genomes by Toll-like receptor (TLR)7 and TLR9, respectively (1, 2). Second, after activation by viruses, cytokines, or CD40L, PDCs diff erentiate into DCs and initiate adaptive immune responses leading to CD4 and CD8 T cell activation (1, 2, 7).
The mechanisms governing these two functions, activation of the innate response refl ected by IFN-α production and of the adaptive response by increased costimulatory molecule expression and antigen presentation, are not clearly defi ned. This ability of PDCs to link the innate and adaptive immune response has many potential clinical applications. Clinical trials using synthetic TLR9 ligands, CpG-containing
immunostimulatory oligonucleotide sequences (ISS), are currently being conducted in allergy, asthma, cancer, and infectious diseases.

...

Read the Full article here

Source: Alliance for Lupus Research
Funded Research


1.5 million

people in the U.S. have Lupus.

90 million

dollars committed to lupus research by the Alliance for Lupus Research.


We're walking across the United States to raise awareness and funds for lupus research.

Can't make it? Join our National Virtual Walk to participate anytime, anywhere.


Show your support by visiting the Alliance for Lupus Research online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.